The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Cited by (1,044)

Items 201–300 of 1,044

1. Heart failure with mid-range or mildly reduced ejection fraction
   Gianluigi Savarese, Davide Stolfo, Gianfranco Sinagra, Lars H. Lund · 2021 · Nature Reviews Cardiology
2. Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
   Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt, Gregorio T. Obrador, Carol A. Pollock, Peter Stenvinkel, Dorine W. Swinkels, Christoph Wanner, Günter Weiß, Glenn Matthew Chertow et al. · 2016 · Kidney International
3. Essential hypertension
   Jan Albert Staessen, Ji‐Guang Wang, Giuseppe Bianchi, W. H. Birkenhäger · 2003 · The Lancet
4. Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy
   Ricardo Rocha, Charles T. Stier, Imre Kifor, Margarita R. Ochoa-Maya, Helmut G. Rennke, Gordon H. Williams, Gail Kurr Adler · 2000 · Endocrinology
5. Congestive Heart Failure: Fifty Years of Progress
   Eugene Braunwald M. D, Michael R. Bristow · 2000 · Circulation
6. Pathophysiology of chronic heart failure
   Milton Packer · 1992 · The Lancet
7. A comprehensive view of sex-specific issues related to cardiovascular disease
   Louise Pilote, Kaberi Dasgupta, Veena Guru, Karin H. Humphries, Jennifer J. McGrath, Colleen M. Norris, Doreen M. Rabi, J. Tremblay, Arsham Alamian, Tracie Ann Barnett et al. · 2007 · Canadian Medical Association Journal
8. Intra-left ventricular electromechanical asynchrony
   Hugues Bader, Stéphane Garrigue, Stéphane Lafitte, Sylvain Reuter, Pierre Jaı̈s, Michel Haı̈ssaguerre, Jacques Bonnet, Jacques Clémenty, Raymond Roudaut · 2004 · Journal of the American College of Cardiology
9. Renal Damage in Primary Aldosteronism: Results of the PAPY Study
   Rossi, Gian Paolo, Bernini, Giampaolo, Desideri, Giovambattista, Fabris, Bruno, Ferri, Claudio, Giacchetti, Gilberta, Letizia, Claudio, Maccario, Mauro, Mannelli, Massimo, Matterello, Mee-Jung et al. · 2006 · Hypertension
10. Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction
    Christian Gratzke, Javier Angulo, Kanchan Chitaley, Yu-Tian Dai, Noel N. Kim, Jaw-Seung Paick, Ulf Simonsen, Stefan Ückert, Eric Wespes, Karl Erik Andersson et al. · 2010 · The Journal of Sexual Medicine
11. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    Borja Ibáñez, Stefan Karl James, Stefan Agewall, Manuel Jesus Antunes, Chiara Bucciarelli‐Ducci, Héctor Bueno, Alida L.P. Caforio, Filippo Crea, John A. Goudevenos, Sigrun Halvorsen et al. · 2017 · Revista Española de Cardiología (English Edition)
12. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
    Dalton Bertolim Précoma, Gláucia Maria Moraes de Oliveira, Antônio Felipe Leite Simão, Óscar Pereira Dutra, Otávio Rizzi Coelho-Filho, Maria Cristina de Oliveira Izar, Rui Póvoa, Isabela de Carlos Back Giuliano, Aristóteles Comte de Alencar Filho, Carlos Alberto Machado et al. · 2019 · Arquivos Brasileiros de Cardiologia
13. Effect of a Standardized Nurse Case-Management Telephone Intervention on Resource Use in Patients With Chronic Heart Failure
    Barbara J. Riegel, Beverly Carlson, Zoe S. Kopp, Barbara LePetri, Dale N. Glaser, Alan N. Unger · 2002 · Archives of Internal Medicine
14. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
    Andrew A. House, Christoph Wanner, Mark J. Sarnak, Ileana L. Piña, Christopher William McIntyre, Paul V. J. Komenda, B.L. Kasiske, Anita M Deswal, Christopher R. deFilippi, John G.F. Cleland et al. · 2019 · Kidney International
15. Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy
    Sato, Atsuhisa, Hayashi, Koichi, Naruse, Mitsuhide, Saruta, Takao · 2003 · Hypertension
16. Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
    Christopher M. Booth, Ian F. Tannock · 2014 · British Journal of Cancer
17. Medical Management of Advanced Heart Failure
    Anju Nohria · 2002 · JAMA
18. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article
    Sharon A. Hunt, William T. Abraham, Marshall H. Chin, Arthur Michael Feldman, Gary S. Francis, Théodore G. Ganiats, Mariell L Jessup, Marvin A. Konstam, DONNA M. MANCINI, Keith Michl et al. · 2005 · Circulation
19. Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
    Murray Epstein, Gordon H. Williams, Myron H. Weinberger, Andrew J. Lewin, Scott L. Krause, Robin Mukherjee, Rajiv Patni, Bruce Beckerman · 2006 · Clinical Journal of the American Society of Nephrology
20. Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models
    Angela J. Grippo, Alan Kim Johnson · 2009 · Stress
21. Systolic Heart Failure
    John J.V. McMurray · 2010 · New England Journal of Medicine
22. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
    Nancy Jeanne Brown · 2013 · Nature Reviews Nephrology
23. Secondary Prevention After Coronary Artery Bypass Graft Surgery
    Alexander Kulik, Marc Ruel, Hani M. Jneid, Thomas Bruce Ferguson, Loren F. Hiratzka, John S. Ikonomidis, Francisco Alejandro López-Jiménez, Sheila M McNallan, Mahesh J. Patel, Veronique Lee Roger et al. · 2015 · Circulation
24. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation
    Constantine L. Athanasuleas, Gerald D. Buckberg, Alfred W.H. Stanley, William Siler, Vincent Dor, Marisa Di Donato, Lorenzo Menicanti, Sérgio Almeida de Oliveira, Friedhelm Beyersdorf, Irving Louis Kron et al. · 2004 · Journal of the American College of Cardiology
25. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation
    Christophe Leclercq · 2002 · European Heart Journal
26. A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
    Gerasimos S Filippatos, Stefan D. Anker, Michael Böhm, Mihai Gheorghiade, Lars Køber, Henry Krum, Aldo Pietro Maggioni, Piotr P. Ponikowski, Adriaan A. Voors, Faiez M. Zannad et al. · 2016 · European Heart Journal
27. The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
    Victor J. Dzau, Elliott Marshall Antman, Henry R. Black, David L. Hayes, JoAnn Elisabeth Manson, Jorge Plutzky, Jeffrey J. Popma, William G. Stevenson · 2006 · Circulation
28. The renin-angiotensin-aldosterone system and its suppression
    Marisa K. Ames, Clarke E. Atkins, Bertram Pitt · 2019 · Journal of Veterinary Internal Medicine
29. Drugs targeting the renin–angiotensin–aldosterone system
    Mohammad A. Zaman, Suzanne Oparil, David A. Calhoun · 2002 · Nature Reviews Drug Discovery
30. Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
    Bertram Pitt, Stefan D. Anker, David A. Bushinsky, Dalane W. Kitzman, Faiez M. Zannad, I‐Zu Huang, on behalf of the PEARL-HF Investigators · 2011 · European Heart Journal
31. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II
    Beckman, Joshua A., Paneni, Francesco, Cosentino, Francesco, Creager, Mark A. · 2013 · European Heart Journal
32. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018
    John James Atherton, Andrew Paul Sindone, Carmine G. De Pasquale, Andrea L Driscoll, Peter Simon Macdonald, Ingrid Hopper, Peter M. Kistler, Tom G. Briffa, James Wong, Walter P. Abhayaratna et al. · 2018 · Heart Lung and Circulation
33. Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
    Kolkhof, Peter, Delbeck, Martina, Kretschmer, Axel, Steinke, Wolfram, Hartmann, Elke, Bärfacker, Lars, Eitner, Frank, Albrecht-Küpper, Barbara, Schäfer, Stefan · 2014 · Journal of Cardiovascular Pharmacology
34. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
    Jeffrey J. Goldberger, MICHAEL E. CAIN, Stefan Hans Hohnloser, Alan Howard Kadish, Bradley P. Knight, Michael S. Lauer, Barry J. Maron, Richard L. Page, ROD S. PASSMAN, David S. Siscovick et al. · 2008 · Journal of the American College of Cardiology
35. Pathophysiology of Hypertensive Renal Damage
    ANIL K. BIDANI, Karen A. Griffin · 2004 · Hypertension
36. Vascular Endothelial Function and Hypertension: Insights and Directions
    Kodlipet Dharmashankar, Michael E. Widlansky · 2010 · Current Hypertension Reports
37. 2013 ESH/ESC Guidelines for the management of arterial hypertension
    Giuseppe Mancia, Robert H. Fagard, Krzysztof Narkiewicz, Josep Redón, Alberto Zanchetti, Michael Böhm, Thierry CM Christiaens, Renata Cífková, Guy De Backer, Anna F. Dominiczak et al. · 2013 · Blood Pressure
38. Reducing the Global Burden of Cardiovascular Disease, Part 2
    Darryl P. Leong, Philip G. Joseph, Martin McKee, Sonia Savitri Anand, Koon Kang Teo, Jon-David Schwalm, Salim Yusuf · 2017 · Circulation Research
39. Heart Failure: Diagnosis, Management and Utilization
    Arati A. Inamdar, Ajinkya Inamdar · 2016 · Journal of Clinical Medicine
40. Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of Cardiology
    Wilfried Müllens, Kevin Damman, Jeffrey Moore Testani, Pieter Martens, Christian Eugen Mueller, Johan P.E. Lassus, W.H. Wilson Tang, Hadi N. Skouri, Frederik Hendrik Verbrugge, Francesco Orso et al. · 2020 · European Journal of Heart Failure
41. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
    Akshay Suvas Desai, John J.V. McMurray, Milton Packer, Karl B Swedberg, Jean Lucien Rouleau, Fabian Chen, Jianjian Gong, Adel R. Rizkala, Abdel Brahimi, Brian Lee Claggett et al. · 2015 · European Heart Journal
42. The incidence and implications of aldosterone breakthrough
    Andrew S. Bomback, Philip J. Klemmer · 2007 · Nature Reviews Nephrology
43. 2014 ESC/EACTS Guidelines on myocardial revascularization
    Stephan Windecker, Philippe H. Kolh, Fernándo Alfonso, Jean‐Philippe Collet, Jochen Cremer, Volkmar Falk, Gerasimos S Filippatos, Christian W. Hamm, Stuart J. Head, Peter Jüni et al. · 2014 · Kardiologia Polska
44. Therapeutic approaches for cardiac regeneration and repair
    Hisayuki Hashimoto, Eric N. Olson, Rhonda Bassel‐Duby · 2018 · Nature Reviews Cardiology
45. Relation of Loop Diuretic Dose to Mortality in Advanced Heart Failure
    Shervin Eshaghian, Tamara B. Horwich, Gregg C. Fonarow · 2006 · The American Journal of Cardiology
46. Combination of Loop Diuretics With Thiazide-Type Diuretics in Heart Failure
    Jacob Colin Jentzer, Tracy A. DeWald, Adrian F. Hernandez · 2010 · Journal of the American College of Cardiology
47. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial
    Ali Ahmed, Michael W. Rich, Thomas E. Love, Donald M. Lloyd‐Jones, Inmaculada Aban, Wilson S. Colucci, Kirkwood F. Adams, Mihai Gheorghiade · 2005 · European Heart Journal
48. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay
    Angelo Auricchio, Christoph Stellbrink, Christian Butter, Stefan Sack, Jürgen Vogt, Anand R. Ramdat Misier, Dirk Böcker, Michael S. Block, Johannes H. Kirkels, Andrew Kramer et al. · 2003 · Journal of the American College of Cardiology
49. Underrepresentation of Renal Disease in Randomized Controlled Trials of Cardiovascular Disease
    Steven G. Coca, Harlan M. Krumholz, Amit X. Garg, Chirag R. Parikh · 2006 · JAMA
50. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management
    J. Malcolm O. Arnold, Peter P. Liu, Catherine Demers, Paul Dorian, Nadia Giannetti, Haissam A. Haddad, George A. Heckman, Jonathan G. Howlett, Andrew P. Ignaszewski, David E. Johnstone et al. · 2006 · Canadian Journal of Cardiology
51. Tackling heart failure in the twenty-first century
    James O. Mudd, David A. Kass · 2008 · Nature
52. QRS duration and mortality in patients with congestive heart failure
    Stephen Iuliano, Susan Gross Fisher, Pamela Karasik, Ross D. Fletcher, Steven N Singh · 2002 · American Heart Journal
53. Role of Diminished Renal Function in Cardiovascular Mortality
    Robert W. Schrier · 2005 · Journal of the American College of Cardiology
54. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
    Esther E. Creemers, Yigal M. Pinto · 2010 · Cardiovascular Research
55. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
    Miguel Sousa‐Uva, Stuart J. Head, Milan Milojevic, Jean‐Philippe Collet, Giovanni Landoni, Manuel Castellà, Joel Dunning, Tómas Guðbjartsson, Nick Linker, Elena Sandoval et al. · 2017 · European Journal of Cardio-Thoracic Surgery
56. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure
    Dei Cas, Alessandra, Khan, Sadiya S., Butler, Javed, Mentz, Robert J., Bonow, Robert O., Avogaro, Angelo, Tschoepe, Diethelm, Doehner, Wolfram, Greene, Stephen J., Senni, Michele et al. · 2015 · JACC Heart Failure
57. Navigating the Crossroads of Coronary Artery Disease and Heart Failure
    Mihai Gheorghiade, George S. Sopko, Leonardo De Luca, Eric J. Velazquez, John D. Parker, Philip F. Binkley, Zygmunt Sadowski, Krzysztof Stanislaw Golba, David Prior, Jean Lucien Rouleau et al. · 2006 · Circulation
58. Economics of Chronic Heart Failure
    Colin Berry, David R. Murdoch, John J.V. McMurray · 2001 · European Journal of Heart Failure
59. The Role of the Autonomic Nervous System in Sudden Cardiac Death
    Marmar Vaseghi, Kalyanam Shivkumar · 2008 · Progress in Cardiovascular Diseases
60. Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction
    James B. Young, Mark E. Dunlap, Marc Alan Pfeffer, Jeffrey L. Probstfield, Alain Cohen Solal, Rainer Dietz, Christopher Bull Granger, J Hradec, Jerzy Kuch, Robert Samuel McKelvie et al. · 2004 · Circulation
61. Advanced Chronic Heart Failure: A Position Statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology
    Marco Metra, Piotr P. Ponikowski, Kenneth Dickstein, John J.V. McMurray, Antonello Gavazzi, Claes‐Håkan Bergh, Alan G. Fraser, Tiny Jaarsma, Antonios A. Pitsis, Paul Mohaçsi et al. · 2007 · European Journal of Heart Failure
62. Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress
    Agostino Virdis, Mário Fritsch Neves, Farhad Amiri, Émilie C. Viel, Rhian M. Touyz, Ernesto L. Schiffrin · 2002 · Hypertension
63. Heart Failure–Associated Hospitalizations in the United States
    Saul Blecker, Margaret M. Paul, Glen B. Taksler, Gbenga G Ogedegbe, Stuart D. Katz · 2013 · Journal of the American College of Cardiology
64. Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology
    Petar M Seferovic, Marija M. Polovina, Johann K Bauersachs, Michael Arad, Tuvia Ben Gal, Lars H. Lund, Stephan Burkhard Felix, Eloisa Arbustini, Alida L.P. Caforio, Dimitrios T. Farmakis et al. · 2019 · European Journal of Heart Failure
65. Electrical Storm Presages Nonsudden Death
    Derek V. Exner, Sergio L. Pinski, D. George Wyse, Ellen Graham Renfroe, Dean A. Follmann, Michael Robert Gold, Karen J. Beckman, James Coromilas, Scott E. Lancaster, Alfred P. Hallstrom · 2001 · Circulation
66. Long-term Renal Outcomes in Patients With Primary Aldosteronism
    Leonardo Alberto Sechi, Marileda Novello, Roberta Lapenna, Sara Baroselli, Elisa Nadalini, GianLuca Colussi, Cristiana Catena · 2006 · JAMA
67. Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
    Mehdi, Uzma F., Adams-Huet, Beverley, Raskin, Philip, Vega, Gloria L., Toto, Robert D. · 2009 · Journal of the American Society of Nephrology
68. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey
    Michel Komajda N, Pablo Lapuerta, Nancy Hermans, José Ramón González‐Juanatey, Dirk Jan van Veldhuisen, Erland Erdmann, Luigi Tavazzi, Philip Alexander Poole-Wilson, Claude Le Pen · 2005 · European Heart Journal
69. Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
    Myron H. Weinberger, Barbara Roniker, Scott L. Krause, Robert Weiss · 2002 · American Journal of Hypertension
70. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice
    Michael G. Usher, Sheng Zhong Duan, Christine Y. Ivaschenko, Ryan A. Frieler, Stefan Berger, Günther Schütz, Carey Nien-Kai Lumeng, Richard M. Mortensen · 2010 · Journal of Clinical Investigation
71. Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment
    Eva M. Boorsma, Jozine M. ter Maaten, Kevin Damman, Wilfried Dinh, Finn Gustafsson, Steven R. Goldsmith, Daniel Burkhoff, Faiez M. Zannad, James E. Udelson, Adriaan A. Voors · 2020 · Nature Reviews Cardiology
72. Diuretic resistance predicts mortality in patients with advanced heart failure
    Gerald W. Neuberg, Alan Bruce Miller, Chris O’Connor, Robert N. Belkin, Peter E. Carson, Anne B. Cropp, David J. Frid, Regina Nye, Milton L. Pressler, JOHN H. WERTHEIMER et al. · 2002 · American Heart Journal
73. Atrial fibrillation in heart failure: what should we do?
    Dipak Kotecha, Jonathan Paul Piccini · 2015 · European Heart Journal
74. Palliative Care in Congestive Heart Failure
    Sarah J. Goodlin · 2009 · Journal of the American College of Cardiology
75. Diagnosis and treatment of primary aldosteronism
    Martín Reincke, Irina Bancos, Paolo Mulatero, Ute I. Scholl, Michael Stowasser, Tracy Ann Williams · 2021 · The Lancet Diabetes & Endocrinology
76. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure
    Takayoshi Tsutamoto, Atsuyuki Wada, Keiko Maeda, Naoko Mabuchi, Masaru Hayashi, Takashi Tsutsui, Masato Ohnishi, Masahide Sawaki, Masanori Fujii, Takehiro Matsumoto et al. · 2001 · Journal of the American College of Cardiology
77. Minireview: Primary Aldosteronism—Changing Concepts in Diagnosis and Treatment
    William F. Young · 2003 · Endocrinology
78. Fibrosis and Cardiac Arrhythmias
    Sanne de Jong, Toon A.B. van Veen, Harold V.M. van Rijen, Jacques M.T. de Bakker · 2010 · Journal of Cardiovascular Pharmacology
79. Sustained Reverse Left Ventricular Structural Remodeling With Cardiac Resynchronization at One Year Is a Function of Etiology
    Martin G. St. John Sutton, Ted J. Plappert, Kathryn E. Hilpisch, William T. Abraham, David L. Hayes, Edward C. Chinchoy · 2006 · Circulation
80. Diabetic cardiomyopathy - A comprehensive updated review
    Ghulam Murtaza, Hafeez Ul Hassan Virk, Muhammad Faisal Khalid, Carl J. Lavie, Héctor O. Ventura, Debabrata Mukherjee, Vijay K. Ramu, Sukhdeep Singh Bhogal, Gautam Kumar, Madhan Shanmugasundaram et al. · 2019 · Progress in Cardiovascular Diseases
81. Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy
    Anton C. Schoolwerth, Domenic A. Sica, Barbara J. Ballermann, Christopher Stuart Wilcox · 2001 · Circulation
82. Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism
    Cristiana Catena, GianLuca Colussi, Roberta Lapenna, Elisa Nadalini, Alessandra Chiuch, Pasquale Gianfagna, Leonardo Alberto Sechi · 2007 · Hypertension
83. The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction
    Bertram Pitt, Gordon H. Williams, Willem J. Remme, Felipe Martínez, Jose Luis Lopez-Sendon, Faiez M. Zannad, James D. Neaton, Barbara Roniker, Steve Hurley, D.M. Burns et al. · 2001 · Cardiovascular Drugs and Therapy
84. Angiotensin II and Aldosterone Regulate Gene Transcription Via Functional Mineralocortocoid Receptors in Human Coronary Artery Smooth Muscle Cells
    Iris Zamir Jaffe, Michael E. Mendelsohn · 2005 · Circulation Research
85. BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular Diseases
    Marc A. Silver, Alan S. Maisel, Clyde W. Yancy, Peter Andrew McCullough, John C. Jr Burnett, Gary S. Francis, Mandeep R. Mehra, William Franklin Peacock, Gregg C. Fonarow, W. Brian Gibler et al. · 2004 · Congestive Heart Failure
86. Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure
    John J.V. McMurray, Bertram Pitt, Roberto Latini, Aldo Pietro Maggioni, Scott David Solomon, Deborah Lynn Keefe, Jessica H. Ford, Anil Verma, Jim Lewsey · 2008 · Circulation Heart Failure
87. Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism
    Gian Paolo Rossi, Maurizio Cesari, Cesare Cuspidi, Giuseppe Maiolino, Maria Verena Cicala, Valeria Bisogni, Franco Mantero, Achille Cesare Pessina · 2013 · Hypertension
88. The new biology of aldosterone
    John Connell, Eleanor Davies · 2005 · Journal of Endocrinology
89. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
    Ducharme, Anique, Swedberg, Karl, Pfeffer, Marc A., Cohen-Solal, Alain, Granger, Christopher B., Maggioni, Aldo P., Michelson, Eric L., McMurray, John J.V., Olsson, Lars, Rouleau, Jean L. et al. · 2006 · American Heart Journal
90. Beneficial effects of potassium on human health
    Feng J. He, Graham A. MacGregor · 2008 · Physiologia Plantarum
91. Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
    Sowers, James R., Whaley-Connell, Adam, Epstein, Murray · 2009 · Annals of Internal Medicine
92. N-Terminal Pro–B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure
    John G. Lainchbury, Richard William Troughton, Kim M. Strangman, CHRISTOPHER M. A. FRAMPTON, Anna P. Pilbrow, Timothy G. Yandle, Amjad Hamid, M. Gary Nicholls, Mark Richards · 2009 · Journal of the American College of Cardiology
93. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors
    Amy McCurley, Paulo Wagner Pires, Shawn B. Bender, Mark A. Aronovitz, Michelle J Zhao, Daniel METZGER, Pierre Chambon, Michael A. Hill, Anne McLaren Dorrance, Michael E. Mendelsohn et al. · 2012 · Nature Medicine
94. Chronic Heart Failure in Congenital Heart Disease
    Karen Stout, Craig S. Broberg, Wendy Book, Frank Cecchin, Jonathan M. Chen, Konstantinos Dimopoulos, Melanie D. Everitt, Michael Α. Gatzoulis, Louise Harris, Daphne T. Hsu et al. · 2016 · Circulation
95. What is the optimal serum potassium level in cardiovascular patients?
    John E. Macdonald, Allan D. Struthers · 2004 · Journal of the American College of Cardiology
96. Guidelines for the management of arterial hypertension
    Philippe van de Borne · 2014 · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
97. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide
    Sagar N. Doshi, Katerina Κ. Naka, Nicola Payne, Christopher J.H. JONES, Moira Ashton, Malcolm J. LEWIS, Jonathan Goodfellow · 2001 · Clinical Science
98. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
    Jeffrey L. Anderson, Cynthia D. Adams, Elliott Marshall Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin et al. · 2011 · Circulation
99. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT
    Roberto Latini · 2004 · European Heart Journal
100. Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
     Michael Bäder · 2010 · The Annual Review of Pharmacology and Toxicology